Literature DB >> 21585262

Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection.

Toshitaka Yajima1.   

Abstract

Virus infection can inflict significant damage on cardiomyocytes through direct injury and secondary immune reactions, leading to myocarditis and dilated cardiomyopathy. While viral myocarditis or cardiomyopathy is a complication of systemic infection of cardiotropic viruses, most individuals infected with the viruses do not develop significant cardiac disease. However, some individuals proceed to develop severe virus-mediated heart disease. Recent studies have shown that viral infection of cardiomyocytes is required for the development of myocarditis and subsequent cardiomyopathy. This suggests that viral infection of cardiomyocytes can be an important step that determines the pathogenesis of viral myocarditis during systemic infection. Accordingly, this article focuses on potential defense mechanisms within the cardiomyocyte against virus infection. Understanding of the cardiomyocyte defense against invading viruses may give us novel insights into the pathophysiology of viral myocarditis, and enable us to develop innovative strategies of diagnosis and treatment for this challenging clinical entity.

Entities:  

Mesh:

Year:  2011        PMID: 21585262      PMCID: PMC3131135          DOI: 10.2217/fmb.11.40

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  116 in total

Review 1.  Myocarditis.

Authors:  A M Feldman; D McNamara
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

2.  Advances in the understanding of myocarditis.

Authors:  P P Liu; J W Mason
Journal:  Circulation       Date:  2001-08-28       Impact factor: 29.690

3.  Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Kanae Matsumoto; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Eileen Foy; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Shin Yonehara; Atsushi Kato; Takashi Fujita
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.

Authors:  R E McCarthy; J P Boehmer; R H Hruban; G M Hutchins; E K Kasper; J M Hare; K L Baughman
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

5.  Cell type-specific involvement of RIG-I in antiviral response.

Authors:  Hiroki Kato; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Satoshi Uematsu; Kosuke Matsui; Tohru Tsujimura; Kiyoshi Takeda; Takashi Fujita; Osamu Takeuchi; Shizuo Akira
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

6.  A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity.

Authors:  Hideo Negishi; Tomoko Osawa; Kentaro Ogami; Xinshou Ouyang; Shinya Sakaguchi; Ryuji Koshiba; Hideyuki Yanai; Yoshinori Seko; Hiroshi Shitara; Keith Bishop; Hiromichi Yonekawa; Tomohiko Tamura; Tsuneyasu Kaisho; Choji Taya; Tadatsugu Taniguchi; Kenya Honda
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-11       Impact factor: 11.205

7.  Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication.

Authors:  R Wessely; K Klingel; K U Knowlton; R Kandolf
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

8.  Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.

Authors:  M Schmidtke; B Glück; I Merkle; P Hofmann; A Stelzner; D Gemsa
Journal:  J Med Virol       Date:  2000-08       Impact factor: 2.327

9.  Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors.

Authors:  Kiyohiro Takahasi; Hiroyuki Kumeta; Natsuko Tsuduki; Ryo Narita; Taeko Shigemoto; Reiko Hirai; Mitsutoshi Yoneyama; Masataka Horiuchi; Kenji Ogura; Takashi Fujita; Fuyuhiko Inagaki
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

10.  Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease.

Authors:  Dingding Xiong; Gil-Hwan Lee; Cornel Badorff; Andrea Dorner; Sang Lee; Paul Wolf; Kirk U Knowlton
Journal:  Nat Med       Date:  2002-07-15       Impact factor: 53.440

View more
  27 in total

1.  [Myocardial protective effect of L-carnitine in children with hand, foot and mouth disease caused by Coxsackie A16 virus].

Authors:  Ya-Jie Cui; Chun-Lan Song; Fang Chen; Peng Li; Yi-Bing Cheng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-08

Review 2.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

3.  Organ-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain.

Authors:  Eiichiro Kawai; Fumitaka Sato; Seiichi Omura; Nicholas E Martinez; Pratap C Reddy; Masaru Taniguchi; Ikuo Tsunoda
Journal:  J Neuroimmunol       Date:  2014-11-08       Impact factor: 3.478

Review 4.  Cardiovascular inflammation: RNA takes the lead.

Authors:  Colton R Martens; Shyam S Bansal; Federica Accornero
Journal:  J Mol Cell Cardiol       Date:  2019-03-14       Impact factor: 5.000

5.  Sporadic isolation of sabin-like polioviruses and high-level detection of non-polio enteroviruses during sewage surveillance in seven Italian cities, after several years of inactivated poliovirus vaccination.

Authors:  A Battistone; G Buttinelli; S Fiore; C Amato; P Bonomo; A M Patti; A Vulcano; M Barbi; S Binda; L Pellegrinelli; M L Tanzi; P Affanni; P Castiglia; C Germinario; P Mercurio; A Cicala; M Triassi; F Pennino; L Fiore
Journal:  Appl Environ Microbiol       Date:  2014-08       Impact factor: 4.792

Review 6.  Update on coxsackievirus B3 myocarditis.

Authors:  DeLisa Fairweather; Katelyn A Stafford; Yoon K Sung
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

7.  Ulinastatin Protects against CVB3-Induced Acute Viral Myocarditis through Nrf2 Activation.

Authors:  Fangqiang Song; Fanpo Kong; Hongqing Zhang; Yongqin Zhou; Ming Li
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

Review 8.  Polymorphisms in genes encoding nonsarcomeric proteins and their role in the pathogenesis of dilated cardiomyopathy.

Authors:  J Staab; V Ruppert; S Pankuweit; T Meyer
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

9.  A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.

Authors:  Jun Gui; Yan Yue; Ruizhen Chen; Wei Xu; Sidong Xiong
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

10.  Severe Fever with Thrombocytopenia Syndrome Accompanied by Invasive Pulmonary Aspergillosis: An Autopsy Case.

Authors:  Kosho Iwao; Takeshi Kawaguchi; Masatoshi Kimura; Chihiro Iwao; Mao Rikitake; Ayako Aizawa; Yumi Kariya; Motohiro Matsuda; Syunichi Miyauchi; Ichiro Takajo; Takumi Kiwaki; Tsuyoshi Fukushima; Hiroaki Kataoka; Tadaki Suzuki; Akihiko Okayama; Kunihiko Umekita
Journal:  Viruses       Date:  2021-06-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.